Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.01 | uM | 8 | 312.50 | 129.17 | 176.00 | 249.25 | 0.7061 | 0.3857 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 312.50 | 129.17 | 215.00 | 249.25 | 0.8626 | 0.7114 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 275.00 | 249.25 | 1.1033 | 1.2185 |
| BT-20 | Erlotinib | 1 | uM | 8 | 312.50 | 129.17 | 261.00 | 249.25 | 1.0471 | 1.0995 |
| BT-20 | Lapatinib | 10 | uM | 8 | 312.50 | 129.17 | 110.00 | 249.25 | 0.4413 | -0.1558 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 303.00 | 249.25 | 1.2156 | 1.4573 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 312.50 | 129.17 | 357.00 | 249.25 | 1.4323 | 1.9212 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 384.00 | 249.25 | 1.5406 | 2.1546 |
| BT-20 | Lapatinib | 1 | uM | 8 | 312.50 | 129.17 | 297.00 | 249.25 | 1.1916 | 1.4060 |
| BT-20 | Linsitinib | 10 | uM | 8 | 312.50 | 129.17 | 383.00 | 249.25 | 1.5366 | 2.1460 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 432.00 | 249.25 | 1.7332 | 2.5718 |
| BT-20 | Erlotinib | 10 | uM | 8 | 312.50 | 129.17 | 295.00 | 249.25 | 1.1836 | 1.3889 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 386.00 | 249.25 | 1.5486 | 2.1719 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 278.00 | 249.25 | 1.1153 | 1.2440 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 312.50 | 129.17 | 117.00 | 249.25 | 0.4694 | -0.0991 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 257.00 | 249.25 | 1.0311 | 1.0656 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 312.50 | 129.17 | 276.00 | 249.25 | 1.1073 | 1.2270 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 285.00 | 249.25 | 1.1434 | 1.3036 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 312.50 | 129.17 | 194.00 | 249.25 | 0.7783 | 0.5356 |
| BT-20 | Linsitinib | 1 | uM | 8 | 312.50 | 129.17 | 236.00 | 249.25 | 0.9468 | 0.8881 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 203.00 | 249.25 | 0.8144 | 0.6108 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 171.00 | 249.25 | 0.6861 | 0.3443 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 211.00 | 249.25 | 0.8465 | 0.6778 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 188.00 | 249.25 | 0.7543 | 0.4855 | |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 312.50 | 129.17 | 156.00 | 249.25 | 0.6259 | 0.2202 |